Transfusion science

journal

Transfusion science is …
instance of (P31):
scientific journalQ5633421

External links are
P6981ACNP journal ID71954
P8375Crossref journal ID2294
P8903HAL journal ID19713
P236ISSN0955-3886
1879-3126
P7363ISSN-L0955-3886
P1055NLM Unique ID9001514
P856official websitehttp://www.sciencedirect.com/science/journal/09553886
P10283OpenAlex IDV8600569
P7662Scilit journal ID1808645
P1156Scopus source ID35768

P495country of originUnited KingdomQ145
P8875indexed in bibliographic reviewScopusQ371467
P407language of work or nameEnglishQ1860
P123publisherPergamon PressQ3375355
P1476titleTransfusion science

Reverse relations

published in (P1433)
Q7388262312th Congress of the European Society of Apheresis. Abstracts
Q486434311991 registry of the French Society of Hemapheresis (SFH): preliminary results for the first year of the on-line computer access file. The Registry Study Group
Q1263218615628727 Extracorporeal virioncidal apparatus
Q77069319A case of idiopathic myelofibrosis with alloimmunization to HLA-identical platelet transfusions not responsive to antibody absorption over protein-A columns
Q77052612A clinical and laboratory study of platelet concentrates produced by pooled buffy coat and single donor apheresis technologies
Q77070705A co-ordinated IT system for the improved management of the blood supply
Q77052581A comparison of in vitro storage markers between gamma-irradiated and non-irradiated apheresis platelet concentrates (APC)
Q77052499A comparison of peripheral blood stem cell apheresis using the Fenwal CS3000 Plus and COBE Spectra
Q33328379A contribution to the indications for platelet transfusion and determination of its therapeutic efficacy
Q57110541A method for the cryopreservation of red blood cells using hydroxyethyl starch as a cryoprotectant
Q45857360A multicentre prospective cohort study of immune function in patients treated with monoclonally immunopurified or resin-purified SNBTS high-potency factor VIII concentrate
Q74107535A pilot study of large volume apheresis of red blood cells and plasma during one donation by allogeneic blood donors
Q77129226A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome
Q33573245A rational approach to regulation of gene therapy in Canada
Q73252080A relationship between glucose metabolism and NO-mediated iron mobilization from cells
Q44827651A risk-to-benefit analysis for central venous catheters
Q33579189A survey of Canadian neonatal blood transfusion practices
Q73689819A survey of autologous blood collection and transfusion in Japan in 1997
Q47333378A system for the supply of platelets suspended in a storage medium including buffy-coat-derived platelet concentrates in combination with "split" apheresis platelets
Q77187713A workshop and symposium on haemopoietic stem cells. 16th April 1996
Q34062749Adoptive allogeneic immunotherapy--history and future perspectives
Q74825524Adsorption therapy with tryptophan-conjugated polyvinyl alcohol gels in 10 patients with acute Guillain-Barré syndrome
Q77157575Advantages of outsourcing the transfusion service
Q33579630Altruism and payment in blood donation
Q45750371An attempt to prepare hepatitis B virus (HBV)-free plasma by ultrafiltration using microporous regenerated cellulose hollow fiber
Q77070696An overview of current opinions on automation in blood transfusion services
Q33560556An overview of laboratory and clinical aspects of leucocyte-depleted blood components
Q33571318Analysis of platelets by flow cytometry
Q73126416Annexin V and platelet antigen expression is not altered during storage of platelet concentrates obtained with the AMICUS cell separator
Q73565662Annexin V and platelet antigen expression is not altered during storage of platelet concentrates obtained with the AMICUS cell separator
Q77139501Annexin V, a new marker of platelet storage lesion: correlation with dMPV
Q45260543Anti-hepatitis C virus serology in patients affected with congenital coagulation defects: a comparative study using three second generation ELISA tests
Q73565668Antifibrotic tendency as complement to inflammatory burnout? Six year IVIG treatment in a case with atherosclerosis and chronic hepatitis C
Q74825538Apheresis activities in The Netherlands
Q74828221Apheresis guidelines from the nurse/operator viewpoint
Q77087943Application of DNA-based technology in blood transfusion
Q33328383Application of therapeutic plasma exchange in hematology
Q33571308Applications of flow cytometry in the analysis of blood leukocytes.
Q33579626Are cytokines in platelet concentrates responsible for febrile transfusion reactions?
Q59157811Are oral contraceptives removed during plasmapheresis?
Q33571324Are there options for donor-derived i.m. anti-D IgG preparations other than to prevent Rh(D) sensitization? The intravenous route
Q33562185Artificial blood substitutes
Q33569381Aspects of platelet storage
Q77157551Assessment of an instrument for automated reagent and specimen dispensing in blood banking
Q61790142Assessment of disease activity in lupus
Q30605437Assessment of perioperative blood transfusion in cardiac surgery using administrative data
Q33881410Autoapheresis and intraoperative blood salvage in oncologic surgery
Q77130341Autologous blood donation in cardiac patients
Q33569412Autologous blood pre-deposit and cell salvage in orthopedic surgery
Q114886807Autologous blood salvage during elective surgery
Q33561328Autologous blood stem cell grafting in hematological malignancies. Present status and future directions
Q33564440Autologous blood stem cell transplantation in myeloma
Q73625014Automatic volumetric capillary cytometry in the routine of an apheresis unit involved in multicomponent collection
Q77070716Automation in blood components processing: NLBTC perspective
Q33571683Automation in quality assurance of blood components and the complementary role of audit
Q64977144Automation in transfusion science.
Q77070703Automation of mandatory testing of blood donations
Q77070713Automation/computerization in blood processing
Q77070699Automation/computerization in donor sessions
Q33582620Availability of clotting factor concentrates in genetically engineered form
Q64905044Bacterial contamination of cellular blood products: the Canadian perspective.
Q33575830Biocompatibility in transfusion medicine
Q33564428Biocompatibility of apheresis harness
Q33577111Biocompatibility of extracorporeal circuits in heart surgery
Q33564444Biocompatibility of extracorporeal immunoadsorption systems
Q74824656Biocompatibility of leukocyte removal filters during bedside leukocyte filtration of red cell concentrates
Q33867790Blood banking issues pertaining to neonatal red blood cell transfusions
Q33328398Blood centres: the effect of cytokine therapy on transfusion medicine
Q77052575Blood component irradiation and prevention of graft-versus-host disease
Q43762849Blood transfusion and deep venous thrombosis in primary total hip and knee replacement surgery: a retrospective analysis of 339 patients
Q33579382Blood transfusion in South Africa
Q33867785Blood transfusion support in pediatric cardiovascular surgery.
Q74828202Bone marrow processing on the Haemonetics V50 cell separator
Q74828237Bone marrow transplantation using unrelated bone marrow donors--a technology in evolution
Q33564459Bone marrow transplants for patients with acute leukemia and myelodysplastic syndrome using unrelated donors
Q64963097Can (should) apheresis supplant whole blood collection?
Q33332765Cascade filtration for TTP: an effective alternative to plasma exchange with cryodepleted plasma
Q33569341Cellular and molecular mechanisms of graft-versus-host disease
Q77820003Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced components
Q73689822Changes in the Canadian blood system: the Krever Inquiry, Canadian Blood Services and Héma-Québec. Krever Commission
Q77110684Changes of haemorheological parameters when using plasma exchange, selective adsorption and membrane differential separation
Q40681374Characterization and transfusion of in vitro cultivated hematopoietic progenitor cells
Q77157595Chronic inflammatory demyelinating polyradiculoneuropathy: superiority of protein A immunoadsorption over plasma exchange treatment
Q33569833Clinical and laboratory aspects of TA-GVHD with reference to perinatal patients and gamma-irradiated red cell components
Q33333390Clinical and laboratory factors that affect the post-transfusion platelet increment
Q33559883Clinical application of functional assays for assessing the red cell antibody activity
Q33930303Clinical application of therapeutic erythrocytapheresis (TEA).
Q33328381Clinical applications of protein A immunoadsorption in thrombocytopenic disorders
Q74824648Clinical applications of stem cell transfusion from cord blood
Q34094824Clinical aspects of hemochromatosis
Q33579647Clinical assessment and measurement of oxygen transport in the critical care setting
Q30665601Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome
Q33562171Clinical significance of renal biopsy in subacute lupus erythematosus
Q33894603Clinical syndromes associated with cold agglutinins
Q33584641Clinical use of recombinant FVIIa (rFVIIa).
Q77141769Clinician's overview of platelet support
Q77070733Cold activation of complement as a marker of hepatitis C viremia in sera from blood donors
Q33564466Collection and transportation of human bone marrow cells from unrelated donors
Q77110725Collection of peripheral blood stem cells (PBSC) after chemotherapy and administration of rhGM-CSF in children weighing less than 17 kg
Q77110753Combined CD34 positive plus CD2 negative selection for effective T-cell depletion as GvHD-prophylaxis in HLA-nonidentical blood progenitor cell transplantation
Q45750362Combining IgG and interferon alpha-2b in chronic hepatitis C virus infection
Q73252059Combining iron chelators with the nucleoside analog didanosine in anti-HIV therapy
Q77087938Comparative clinical studies of platelet concentrates: effects on clinical outcome and the use of healthcare resources. NBS Platelet Study Group
Q74826035Comparison of four filters for leukocyte depletion of single donor plateletapheresis products
Q77139494Comparison of performance of six different cell separators in collecting peripheral blood mononuclear cells
Q33332144Comparison of platelet immunity in patients with SLE and with ITP.
Q73252074Competition studies of L1-deferiprone with copper and iron. Possible implications on efficacy, toxicity and new therapeutic applications
Q77051959Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns
Q33584632Computer assisted prospective review of blood product utilization: a large hospital experience
Q33584626Consensus conference on platelet transfusion. Final statement
Q52466094Continuous flow cell separator use for bone marrow processing.
Q33881416Corrective and preventive action
Q73325655Cost containment in platelet transfusion: clinical and technical aspects
Q73625028Cost effectiveness of quality assurance in plateletpheresis
Q33559477Costing complexities in mixed apheresis
Q77139467Cross-flow microfiltration of blood through an extracorporeal device: a study in parameterization
Q33579171Current methods for the preparation of platelet concentrates: laboratory and clinical aspects
Q73689861Current position on preparation and quality of leucodepleted platelet concentrates for clinical use
Q74821879Current trends: evolving concepts in transfusion medicine. The need for standardization of cryoprecipitate-derived fibrin adhesive
Q33571695Current trends: evolving concepts in transfusion medicine. Leukodepleted cellular blood components for prevention of transfusion-associated graft-versus-host disease
Q33562178Current trends: evolving concepts in transfusion medicine. Leukoreduced blood components: "you can filter now or you can filter later.".
Q41042650Current trends: evolving concepts in transfusion medicine: potential alternatives to platelet transfusion
Q64389277Cyclosporin and plasmapheresis in treatment of progressive systemic lupus erythematosus (pSLE)
Q74107507Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction
Q33569836Cytokines in platelet concentrates
Q77137580Cytokines in platelet concentrates: a comparison of apheresis platelet (haemonetics) and filtered and unfiltered pooled buffy-coat derived platelet concentrates
Q33579136Cytokines to reduce platelet transfusions: non-TPO cytokines
Q126388730Cytokines to replace platelet transfusions
Q77139478Decreasing blood donor exposure in the neonates by using dedicated donor transfusions
Q33579423Dendritic cells: therapeutic potentials
Q73252044Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy
Q74107514Detection of nucleic acid sequences from bacterial species with molecular genetic methods
Q77819999Developing effective working partnership with manufacturers
Q77110762Development of tumor B-cell lymphocyte hybridoma (TBH) autovaccination. Results of a phase I-II clinical trial
Q77141788Differential reduction in lymphocyte and granulocyte content by removal of the buffy coat from fresh and overnight-stored blood. Comparison of manual and automated blood processing systems
Q33334679Difficulties in the management of an incomplete form of refractory thrombotic thrombocytopenic purpura, the usefulness of vincristine
Q77497516Discontinuous automated calcium supplementation during thrombocytapheresis with the haemonetics MCS+ version C
Q73689832Distribution of normal prion protein in blood
Q73689874Does bacterial contamination of platelet concentrates influence the leucocyte content and the rate of platelet storage lesion?
Q74829274Donor hemapheresis in France at the start of 1992
Q77052509Double-lumen inferior vena cava catheters for peripheral stem cell apheresis and transplantations
Q53922996Dry platelets with the Dideco Excel apparatus.
Q73086630Early total white blood cell recovery is a predictor of low number of apheresis and good CD34(+) cell yield
Q73835298Editorial
Q93937549Editorial
Q93944176Editorial
Q93932867Editorial
Q74107502Editorial: focus on quality assurance research development
Q77052578Effect of 25 Gy gamma irradiation on storage stability of three types of platelet concentrates: a comparative analysis with paired controls and random preparations
Q33569352Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors
Q77087954Effect of cold storage on the haemostatic cascade systems
Q74823899Effect of filtration, storage and platelet suspension media on platelet indices
Q77819952Effect of intravenous immunoglobulin therapy on plasma complement
Q77139485Effect of long-term platelet donation on lymphocyte subsets and plasma protein concentrations
Q77137586Effect of pH and buffering condition on dMPV of three types of platelet concentrates
Q77110712Effect of storage conditions on the CD34+ counts in flow cytometric analysis after anticoagulation of samples with EDTA
Q74825306Effective concentration of bone marrow mononuclear cells using density gradient separation within an automated cell separator
Q74828199Effectiveness of lymphocytapheresis in a patient with ankylosing spondylitis
Q73329576Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery
Q73252065Endocrine problems in ex-thalassemic patients
Q77127079Enhancing the efficacy of preoperative autologous blood donation by erythropoietin
Q33867803Establishment of new national proficiency testing schemes for leucodepleted blood components: UK.
Q73689840Evaluating leucodepletion systems suitable for routine use
Q30304029Evaluation of CAPTURE CMV solid phase testing over the allowable shelf-life of red blood cells (adenine-saline added).
Q40769014Evaluation of Cobe Trima for the collection of blood components with particular reference to the in vitro characteristics of the red cell and platelet concentrates and the clinical responses to transfusion
Q77141798Evaluation of a new 5-log filter or packed red cells leucodepletion
Q77820021Evaluation of sampling procedures for quality monitoring of red cell concentrates: the need for improving sampling and sample handling techniques of red cell concentrate
Q74823570Evaluation of the Fresenius cell separator AS 104 for harvesting peripheral blood stem cells in pediatric patients
Q74828227Evaluation of the Organon Teknika Plasmapur system with new software and two types of filter
Q33328387Evidence for proteolytic cleavage of covalently bound protein A from a silica based extracorporeal immunoadsorbent and lack of relationship to treatment effects
Q33332147Ex vivo expansion of megakaryocytes
Q123024452Experiments on enrichment of peripheral blood progenitor cells in an electric field
Q77052604Exploiting temperature dependence to improve selectivity in membrane-based plasmapheresis
Q74823891Extending the storage of red cells at 4 degrees C
Q33573565Extracorporeal granulocytapheresis for cancer and rheumatoid arthritis
Q33569398Extracorporeal photochemotherapy: a scientific overview
Q33569404Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders
Q33894607Factors influencing the outcome of leucodepletion system
Q77110719Factors influencing the timing of peripheral blood stem cell collection (PBSC)
Q28372927Falsely low calcium measurements after high volume plasma exchange in a patient with liver failure
Q77087931Fibrin sealant: update on clinical studies
Q61053604First results obtained in France with the latest model of the Fresenius cell separator: AS 104
Q73126424Flow cytometric analysis of platelet function in stored platelet concentrates
Q77820025Flow cytometric determination of residual leucocytes in filter-depleted blood products: an evaluation of Becton-Dickinson's LeucoCOUNT system
Q33571302Flow cytometry in the management of infection with human immunodeficiency virus
Q38479592Flow cytometry related to hematopoietic malignancy
Q33571314Flow cytometry related to red cells
Q73252039Free radical formation and oxyhemoglobin oxidation in beta-thalassemic red blood cells in the presence of prooxidants: effects of the free radical scavenger rutin and oral chelator L1
Q77819956French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP)
Q33328410Future directions in utilization review: the role of transfusion algorithms
Q40930459Future trends for provision of safer blood components/blood products
Q33579411Gene therapy for AIDS.
Q33573235Gene therapy in Europe
Q33573250Gene therapy with physical methods of gene transfer
Q33579418Gene transfer into human haematopoietic stem cells
Q33579429Graft T-cell depletion as a prerequisite for the modulation of alloreactivity after haematopoietic stem cell transplantation
Q33569362Graft-versus-host disease and the development of late complications
Q40883877Growth factors and thrombopoietin--impact on future patterns of platelet use.
Q30321980HIV and blood transfusion in sub-Saharan Africa.
Q60255539HIV-1 Detection and Subtyping by PCR and Heteroduplex Mobility Assay in Blood Donors: Can These Tests Help to Elucidate Conflicting Serological Results?
Q73086637Haematopoietic stem cell transplantation
Q73252077Haematopoietic stem cell transplantation for the management of haemoglobinopathies in Greek patients
Q77110679Haemorheological changes in mixed cryoglobulinaemia during apheresis treatment
Q74828206Hazards of apheresis and the U.K. approach to guidelines
Q41210072Hemapheresis and hemorheology
Q77087969Hemapheresis listening post. Certification of the hemapheresis practitioner HP (ASCP)
Q41012297Hemapheresis versus intravenous IgG: a debate for the 21st century
Q77052590Hematopoietic engraftment from a minimal number of apheresis procedures after mobilization of peripheral blood stem cells with chemotherapy and rhG-CSF
Q33579405Hematopoietic stem cell expansion
Q77157558Hemorheology and therapeutic hemapheresis
Q44951817Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population
Q42992857Hepatitis C virus RNA testing by nested PCR in blood preparations in Yugoslavia
Q39172522Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission
Q33575841How can we improve platelet preparation and storage?
Q30658058Hydroxamate analog libraries and evaluation of their iron affinity
Q73325644Hypercoagulability state in hip and knee surgery: influence of ABO antigenic system and allogenic transfusion
Q77820029III-7 evaluation of IMAGN 2000: a new system for absolute leucocyte count
Q30570471ISBT 128--a new international standard for labelling and data management in blood transfusion
Q30571288IVBT-documented platelet function correlates with flow cytometric data
Q73086648IVIG as a nonspecific accelerator of restitutio ad integrum
Q74107530IgM alloantibody detection by M-MPHA, a new solid-phase assay system
Q33569391Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases
Q74821872Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992
Q77157589Immunoadsorption using the Excorim treatment system
Q77157616Immunoadsorption--a new therapeutic possibility for multiple sclerosis?
Q77157585Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose
Q33581254Immunological effects of therapeutic immunoadsorption with respect to biocompatibility
Q33579621Immunomodulation, autoimmunity and haemostatic dysfunctions
Q77110696Immunosorbent for IgG apheresis: an in vitro study
Q56932742Impact of autologous blood transfusion on blood support in general thoracic surgery: Analysis of 969 patients over a 5-year period
Q77110758Improved lectin agglutination method for T-cell depletion of HLA-mismatched bone marrow grafts in children
Q74825536Improvement of separation efficiency and concentrate purity of the Fresenius cell separator AS 104: results of a multicenter study. Haemapheresis Scientific Workshop Group of DGTI
Q73882618Improvement of visual acuity in patients suffering from diabetic retinopathy after membrane differential filtration: a pilot study
Q74821881In utero fetal liver cell transplantation in the treatment of immunodeficient or thalassemic human fetuses
Q62090539In vitro analysis of platelet concentrates stored in the presence of modulators of 3′,5′ adenosine monophosphate, and organic anions
Q74828231In vitro evaluation of a new dual screen microaggregate filter
Q77157536In-process cell counts during preparation of platelet concentrates from buffy coats
Q77137653Incidence of electrocardiographic changes during cytapheresis using an intermittent flow centrifuge, haemonetics V50 and a continuous flow centrifuge, AS104
Q73882614Increased anticoagulant osmolality improves separation of leukocytes from red blood cells (RBC)
Q77172480Indications for a cost-saving policy in routine flow cytometry
Q74825533Initial validation and quality control of platelet concentrates prepared by apheresis
Q33575849Integration of biological, procedural, apheresis principles of peripheral blood stem cell transplantation programs
Q74828247Intensive plasmapheresis as an alternative therapy for intractable pruritus of primary biliary cirrhosis
Q33579177International forum: Europe. Buffy-coat-derived platelet concentrates: Swedish experience
Q77069308International forum: France. The national survey of plasma exchange and therapeutic cytapheresis in France
Q47715932International forum: Japan report on informed consent in blood transfusions
Q45206452International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: is it cost effective?
Q33571689International forum: Saudi Arabia. Peripheral blood stem cell harvest in Saudi Arabia. A review of the first decade
Q77185707International forum: The U.K. A forum discussion on circles of dependence of quality in the blood transfusion community
Q33579183International forum: U.K. Consensus conference on unrelated donor BMT: its use in leukaemias and allied disorders
Q77819972International views on universal leucodepletion: the perspective in Germany
Q95781295International views on universal leucodepletion: the perspective in NBS, England
Q53345718International views on universal leucodepletion: the perspective in NBS, Ireland.
Q52807129International views on universal leucodepletion: the perspective in Portugal.
Q77819968International views on universal leucodepletion: the perspective in The Netherlands
Q33578186Intraoperative hemodilution and autologous platelet rich plasma collection: two techniques for collecting fresh autologous blood
Q33569407Intraoperative red cell retrieval in a multiple theatre programme
Q33329015Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura
Q33329019Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action
Q73463326Is Brazil entering a new age?
Q93948610Is Brazil entering a new age?
Q74825302Italy and apheresis: a fresh look at the end of 1991
Q47224536L1 effects on reactive oxygen (ROS) and nitrogen species (RNS) release, hemoglobin oxidation, low molecular weight antioxidants, and antioxidant enzyme activities in red and white blood cells of thalassemic patients
Q77069314LDL-apheresis in treatment of two patients with heterozygous familial hypercholesterolemia and extremely elevated lipoprotein (a) levels
Q33559466LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia
Q40783830LDL-apheresis: questions for the future
Q73689859Laboratory and clinical aspects of platelet concentrates
Q33579387Langerhans islet preparation in cell transplantation
Q33573240Legal and ethical challenges in gene therapy
Q33569386Leucocyte contamination of platelet products
Q74825299Leucocyte depletion of neocyte-rich red blood cell concentrates by use of immunomagnetic beads
Q53982535Leucocyte fragments in 'prestorage-leucodepleted' blood products: a qualitative analysis.
Q73689851Leucodepletion and regulatory aspects in Germany
Q73689842Leucodepletion monitoring by flow cytometry (Becton-Dickinson): from universal to statistical process monitoring
Q34062739Leucodepletion process performance variation: is it dependent on the batch of filters, the processing centre or the counting technology?
Q73689853Leucofiltration of sickle cell trait blood "the blocker": NBS London & S.E. experience
Q73689857Leucofiltration, retention/generation of soluble prion and annexin V and storage of blood components
Q74825526Leukocyte-depleted platelets prepared from pooled buffy coat post-transfusion increment and "in vitro bleeding time" using the Thrombostat 4000/2
Q77820012Leukocyte-poor platelet concentrates in routine production: preparation and cost
Q77820009Leukodepleted blood components: definition of a standard
Q77110690Lipoprotein(a)-apheresis in the secondary prevention of coronary heart disease
Q77819995Logistical problems of supplying leucodepleted blood components within the national blood service
Q73689865Lyophilized platelets: continued development
Q33581244Making Landsteiner's discovery superfluous: safety and economic implications of a universal group O red blood cell supply
Q33584646Mammalian recombinant coagulation proteins: structure and function
Q33329011Management of children with acute and chronic immune thrombocytopenic purpura
Q33329013Management of chronic autoimmune thrombocytopenic purpura (ITP) in adults
Q33894599Management of cold agglutination syndrome
Q33569357Management of graft-versus-host disease
Q77157543Manual and automated methods for the determination of leukocyte counts at extreme low levels: comparative evaluation of the Nageotte chamber and the Abbott Cell Dyn 3500 analyser
Q33328363Massive blood transfusion: the blood bank perspective
Q74826032Membranes and polymer structures--biocompatibility aspects with respect to production limits
Q33579166Methods for platelet preparation in Italy in 1996.
Q33579399Methods of CD34+ cell separation: comparative analysis
Q77052567Microchimerism after transfusion: the spectrum from GVHD to alloimmunization
Q33573255Microencapsulation--an alternative approach to gene therapy
Q77110677Modification of activation-dependent platelet antigens CD62p and CD63 during haemodialysis
Q33569346Molecular and biological actions of cyclosporin A and FK506 on T cell development and function
Q33573542Molecular biology of human immunodeficiency virus type-1.
Q33894597Molecular characterization of cold agglutinins
Q33579393Monocyte/macrophages as effector cells in cancer immunotherapy
Q73252067Morbidity and mortality of iron intoxication in adult patients with thalassemia major, and effectiveness of chelation
Q74825537Multicenter study of standardization of cell counting. Haemapheresis Scientific Workshop Group of DGTI
Q73252055Multiple effects of iron chelators on molecules controlling cell cycle progression
Q73126421Multiple red blood cell antibodies produced by donor B lymphocytes after ABO-matched allogeneic bone marrow transplantation
Q43214430NBA/NBS perspective on nvCJD.
Q77819989NBS approaches to the approval of suppliers of leucodepletion systems
Q54472755National evaluation of IMAGN 2000 for quality monitoring of leucodepleted red cell and platelet concentrates: comparison with flow and Nageotte.
Q50136000National survey of hemapheresis practice in Turkey (1998).
Q33563055Neocyte transfusion: a current perspective
Q74828250New "leap-frog" technique for autologous blood donation
Q33565539New approaches for bone marrow purging
Q40930464New horizons in blood transfusion medicine: present status and future trends
Q74107525New plasma-reduced synthetic media, Fukushima cocktails, for the storage of platelets for transfusion
Q33564433New strategies for plasma exchange in systemic vasculitis
Q73252052Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermedia
Q33328406Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC).
Q73325651Nutricel as an additive solution for neonatal transfusion
Q33857225On the removal of diffusable substances from the circulating blood by means of dialysis. Transactions of the Association of American Physicians, 1913.
Q74828217One American approach to apheresis guidelines
Q77819985Operational and research approaches to universal leucodepletion in Scotland
Q33565364Optimal venous access
Q77110746PBSC collection from G-CSF primed donors
Q42998818PCR testing for HCV in anti-HCV negative blood donors involved in the so called HCV +ve post-transfusion hepatitis
Q33569759Perfluorochemical-based artificial oxygen carrying red cell substitutes
Q33867781Perioperative autologous blood donation in children
Q73325649Peripheral blood stem cell collection and transplantation using the Haemonetics Multi Component System
Q73565665Peripheral blood stem cell collection and transplantation using the haemonetics multicomponent system
Q77087961Peripheral blood stem cell collection from healthy donors for allogeneic transplantation
Q34062744Peripheral blood stem cell collection: the interaction of technology, procedure, and biological factors
Q74829269Peripheral blood stem cell transplantation for breast cancer patients with bone marrow metastases using GM-CSF priming
Q33561324Peripheral blood stem cell transplantation: approaches to an optimal blood stem cell collection
Q33569371Peripheral blood stem cell transplants in lymphoma
Q40883890Perspective in platelet transfusion: current challenges and future trends
Q40637987Perspective on Nordic views on selective/universal leukodepletion
Q74821870Perspectives for apheresis in hypercholesterolaemia
Q33561332Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation
Q33930298Pharmacological therapies to minimise platelet transfusion
Q52083299Physical determinants of line pressures during apheresis.
Q77070739Physico-chemical properties of membranes of recovered erythrocytes in blood autologous transfusion: a study using fluorescence technique
Q33579635Physiology and pathophysiology of blood volume regulation
Q77052587Pilot study of a new treatment concept for acute Guillain-Barré syndrome
Q74825525Plasma exchange and selective adsorption in Guillain-Barré syndrome--a comparison of therapies by clinical course and side effects
Q74830916Plasma exchange for Refsum's disease
Q43713814Plasma exchange for homozygous familial hypercholesterolaemia: the Cape Town experience
Q33562457Plasma exchange in Guillain-Barré syndrome and related disorders
Q33573548Plasma exchange in chronic inflammatory demyelinating polyneuropathies
Q33563051Plasma exchange: a potential role in promyelocytic leukemia--disseminated intravascular coagulopathy
Q33857226Plasma removal with return of corpuscles (plasmaphaeresis). The Journal of Pharmacology and experimental therapeutics Vol. V. No. 6, July, 1914.
Q33584635Plasmapheresis in myasthenia gravis. A survey
Q49116942Plasmapheresis--the Indiana connection
Q127412678Platelet Depletion During Pediatric Peripheral Blood Progenitor Cell (PBPC) Harvesting
Q33329005Platelet autoantibodies in immune thrombocytopenic purpura
Q33329002Platelet cold agglutinins: a flow cytometric analysis
Q60313669Platelet concentrates from buffy coats: Improved conditions for preparation and evaluation in routine clinical use
Q33579161Platelet concentrates in Germany
Q77087988Platelet loss during peripheral blood progenitor cell collections
Q33579150Platelet production methods in the United Kingdom
Q73689863Platelet products, where to?
Q33560770Platelet storage in a liquid environment
Q74826026Platelet storage lesions: analysis of platelet membrane glycoproteins and platelet-derived microparticles by fluorescence-activated flow cytometry
Q33894594Platelet storage--1999 as good as it gets?
Q40883884Platelet therapy: current opinions on laboratory and clinical aspects
Q73625045Plateletapheresis: instrumentation validation
Q33575835Plateletpheresis: what's new?
Q33581221Pooled platelet concentrates: maybe not fancy, but fiscally sound and effective
Q77141781Possible implication of sterile connecting device in contamination of pooled platelet concentrates
Q33335283Post-transfusion thrombocytopenia in recipients with anti-HLA antibody
Q77141810Potential Creutzfeldt-Jakob disease (CJD) exposure: to notify or not to notify
Q77819959Potential clinical benefits and cost savings of universal leucocyte-depletion of blood components
Q73625007Pre-separation storage of whole blood: the effect of temperature on red cell 2,3-diphosphoglycerate and myeloperoxidase in plasma
Q74107546Pre-separation storage of whole blood: the effect of temperature on red cell 2,3-diphosphoglycerate and myeloperoxidase in plasma
Q77052607Preclinical testing of lyophilized platelets as a product for transfusion medicine
Q41738482Preliminary experience with plasma exchange in patients with ulcerative colitis
Q33328403Prenatal determination of human platelet antigen type 4 by DNA amplification of amniotic fluid cells.
Q73252030Preoperative autologous blood donation in hip surgeries
Q74826029Preparation of random donor leukocyte-poor platelets by cytapheresis
Q33560774Prestorage leukocyte reduction of cellular blood components
Q44921713Prevention of infections transmissible by blood derivatives
Q73252032Primary and secondary haemochromatosis
Q30664845Principles of flow cytometry
Q33583500Principles of risk management
Q73689829Prions and blood transfusion
Q33579155Production of platelet concentrates in Switzerland
Q57390421Prospects of gene therapy for genetic skeletal muscle disease
Q77157614Protein A immunoadsorption (i.a.) in renal transplantation patients with vascular rejection
Q33328408Protein A immunoadsorption in alloimmunized patients refractory to platelet transfusions and in patients with treatment-resistant immune thrombocytopoenic purpura
Q28373007Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome
Q73325682Quality assurance in thrombapheresis
Q73325686Quality assurance system in haemapheresis according to current good manufacturing practice
Q74829272Quality control in stem cell processing for autotransplantation
Q77141774Quality is a matter of mind: proposed quality improvement through the implementation of best practice
Q33809954Quality monitoring of platelet concentrates: the need for standardization/harmonization of cellular content and assessment of platelet functional reserve
Q33569841Quality of leukodepleted blood products
Q33569375Quality of plasma for fractionation--does it matter?
Q33581232Quality pays--in every business!
Q73325658Quality, ISO 9002 and haemapheresis service
Q73126412Quantitative PCR for counting residual white blood cells in blood products
Q50243509Recent developments in humanized MAbs for immunotherapy: a personal tribute to Dr. Martin Lockwood.
Q45857366Recombinant factor VIIa (r-FVIIa) in haemophilia management
Q33569764Recombinant growth factors
Q77051948Recovery of both acute massive pulmonary hemorrhage and acute renal failure in a systemic lupus erythematosus patient with lupus anticoagulant by the combined therapy of plasmapheresis plus cyclophosphamide
Q33579660Red cell transfusion in specific circumstances
Q33579656Red cell transfusion therapy in the critical care setting
Q34094844Regulation of intracellular iron levels in iron-acceptor and iron-donor cells
Q33569365Regulatory review of cellular and gene therapies: an overview of the process.
Q33857281Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections.
Q73689834Removal of abnormal prion protein by plasma fractionation
Q33573559Removal of anti-A/B antibodies for successful kidney transplantation between ABO blood type incompatible couples
Q73325689Results of an open, longitudinal multicenter LDL-apheresis trial
Q77051964Results with new software for plateletpheresis systems
Q38891109Revival of the Ugandan Blood Transfusion System 1989: an example of international cooperation
Q73325663Rheological behaviour of red blood cells suspended in hemoglobin solutions. In vitro study comparing dextran-benzene-tetra-carboxylate hemoglobin, stroma free hemoglobin and plasma expanders
Q74823560Risk management in transfusion medicine
Q74823563Risk management in transfusion medicine: a hospital transfusion service perspective
Q53667308Risk management in transfusion: an historical overview.
Q33559471Role of LDL apheresis in the management of hypercholesterolaemia
Q74825532Routine quality assurance requirements for apheresed platelets
Q33573538Royal College of Physicians of Edinburgh Consensus Conference on autologous transfusion: final consensus statement
Q77141760Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists consensus conference on anti-D prophylaxis 7-8 April 1997
Q77141794Satisfactory recovery and viability of stem cells cryopreserved at high cell concentration
Q55242127Screening blood products for HTLV-I: what is the best approach?
Q73689845Selective or universal leucodepletion: the Italian experience
Q74822446Separation of buffy coat using the top and bottom drainage system: reduction of red blood cell loss
Q77052622Shall red cell units stand upright, lie flat or be mixed during storage? In vitro studies of red cells collected in 0.5 CPD and stored in RAS2 (Erythrosol)
Q77137641Should cardiac disease prevent autologous blood donation?
Q33581209Should hospitals collect blood components? Yes: hospitals put patients first
Q77157570Should hospitals collect blood components?: no
Q73252026Single automated donor plateletpheresis increases the plasma level of proinflammatory cytokine tumor necrosis factor-alpha which does not associate with endothelial release markers von Willebrand factor and fibronectin
Q33581227Single donor platelets: can we afford to use them? Can we afford not to use them?
Q33565552Some principles of blood stem cell transplantation
Q77070719Some ramblings on automation for a hospital blood transfusion laboratory
Q33573553Specific removal of anti-acetylcholine receptor antibodies in patients with myasthenia gravis
Q74822435Standardization of plateletpheresis products
Q33575845State of the art in platelet transfusion therapy
Q77172457Statistical process validation of leucoreduced blood components
Q77051981Stem cell procurement and transplantation in paediatric patients
Q77110732Stem cell separation in paediatric patients
Q74829259Stem cell transfusion
Q33565533Stem cell transfusion from long-term marrow culture
Q33565527Stem cells for grafting
Q40879956Stem cells: what's happening? Current concepts and recent advances
Q77201236Stem cells: what's happening? Focus on quality assurance, GMP and regulatory aspects
Q95796665Stem cells: what's happening? Megakaryocyte growth and development factor and platelet aggregation
Q77186543Stem cells: what's happening? Workshops and symposia on the subject of haematopoiesis
Q74823896Storage of saline-adenine-glucose-mannitol suspended red cells in diethylhexyl phtalate and butyryl-n-trihexyl-citrate plasticized polyvinyl chloride containers. An in vitro comparative study
Q77052594Studies on IgA class circulatory red cell antibodies--I. Preparation and identification of IgA class anti-A,anti-B
Q77052598Studies on IgA class circulatory red cell antibodies--II. Properties of IgA class anti-A,anti-B
Q77157566Successful prevention of posttransfusion hepatitis B by the combined use of immunoglobulin, vaccine and interferon
Q44221603Successful treatment of HIV-related vasculitis with peripheral neuropathy with short-term steroids followed by the association of zidovudine and plasmapheresis
Q45857377Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy
Q60218216Symposium highlights: Future prospects for gene therapy
Q77819930Symposium on Hemapheresis, international forum. Dordrecht, The Netherlands. Abstracts
Q33582602Synchronization of plasma exchange and adjuvant treatments
Q73689837Systematic RBC leucodepletion in France: where are we after six months?
Q34062753T cell depletion of allogeneic stem cell grafts with anti-CD 52 monoclonal antibodies: the Ulm experience from 1983-1999.
Q77051994Technical and clinical experience with protein A immunoadsorption columns
Q77110739Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donors
Q40879960The 90s paradox: QA efforts reduce total quality
Q33569418The Allen Latham Award Lecture: specific immunotherapy for autoimmune disease
Q33809949The Canadian Apheresis Group and therapeutic plasma exchange
Q33329021The Canadian experience using plasma exchange for immune thrombocytopenic purpura. Canadian Apheresis Group
Q74828214The French approach to donor apheresis guidelines
Q74828213The French approach to therapeutic haemapheresis guidelines
Q74828209The German approach to apheresis guidelines
Q73689825The Second International Forum on variant CJD and leucodepletion: UK
Q38495096The Sydney Children's Hospital experience with the oral iron chelator deferiprone (L1).
Q73625035The UK strategy for monitoring universal leucodepletion
Q77087921The WAA next presidency--Genoa as a micro-image of apheresis evaluation over the next few years
Q52542003The arguments for directed donations.
Q41638064The biological significance and therapeutic potential of megakaryocyte growth and development factor (Mpl-ligand).
Q33443420The blood bank and hepatitis G.
Q33329007The cellular immunology associated with autoimmune thrombocytopenic purpura: an update.
Q52381192The clinician's approach to the management of risk.
Q73882621The correlation between erythropoiesis and thrombopoiesis as an index for pre-operative autologous blood donation
Q77087973The current status of extracorporeal immunomodulation
Q34094832The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values
Q73252082The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values
Q33569769The development of hemoglobin solutions as red cell substitutes: hemoglobin solutions
Q73252049The effect of deoxynucleosides on cell proliferation of peripheral blood lymphocytes treated with deferoxamine or hydroxyurea
Q73329583The efficiency of PBPC collections and the relationship to the precollection concentration of CD 34+ cells in blood
Q73625019The flow rate significantly influences the leukocyte depletion rate during prestorage in-line filtration of platelet concentrates
Q74822439The growing practice of "splitting" double-dose apheresis platelet products
Q31307005The history of idiopathic thrombocytopenic purpura (ITP).
Q33579144The impact of peripheral blood stem cell transplants (PBSCT) on platelet usage
Q73325675The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
Q34094818The importance of non-transferrin bound iron in disorders of iron metabolism
Q77137627The influence of peri-operative blood transfusion during radical hysterectomy on the prognosis of uterine cervical cancer
Q74825296The organization and operation of blood transfusion services in Andalusia
Q33579641The physiology of oxygen transport
Q73329579The platelet level indicates the erythropoietic capacity for preoperative autologous blood donation
Q33564473The preparation of platelet concentrates by the light-spin/hard-spin technique
Q33328358The problem of under utilization of therapeutic hemapheresis
Q74829127The problem of vascular access for hemapheresis
Q77137592The quality of clinical FFP, cryoprecipitate and cryosupernatant derived from single donor apheresis procedures and random donations collected in a BAT system: assessment of the activity states of FVIII, contact activation, microvesicle content and
Q33582614The red blood cell utilization review experience
Q33579652The red cell storage lesion and its implication for transfusion
Q43214433The risk of transmission of nvCJD by blood transfusion and the potential benefits of leucodepletion
Q33569336The role of alloreactive cytotoxic and lymphokine-secreting T lymphocytes in the development of acute graft-versus-host disease
Q33582595The role of flow cytometry in improving biocompatibility in transfusion medicine
Q73835304The role of in process qualification in quality improvement of the haemonetics MCS plus leucodepleted platelet concentrate
Q40920361The storage quality of apheresis platelets--analysis of results from seven different cell separators
Q46656698The supply of blood products in 10 different systems or countries
Q77820017The timing of leuko-depletion of apheresis platelets with a Sepacell PLS-5A filter does not affect glycoprotein IIb/IIIa-dependent platelet function in vitro
Q33582608The transfusion audit as a tool to improve transfusion practice: a critical appraisal
Q33582626The transfusion audit as an educational tool
Q33581216The transfusion service is an integral and important component of the hospital and should not be outsourced
Q77052601The use of therapeutic plasma exchange for treatment of acute polyradiculoneuropathy
Q33564449The use of unrelated bone marrow transplantation in the treatment of chronic myelogenous leukemia
Q33328414Therapeutic cytokine stimulation of thrombocytopoiesis
Q33581248Therapeutic immunoadsorption--its role in clinical practice
Q39513475Therapeutic leukapheresis
Q33867776Therapeutic plasma exchange and cytapheresis in pediatric patients
Q77157600Therapy of coagulation factor VIII autoantibodies with long-term extracorporeal protein A adsorption and immunosuppression
Q40613541Three episodes of delayed hemolytic transfusion reactions due to multiple red cell antibodies, anti-Di, anti-Jk and anti-E.
Q77137601Thrombopoietin
Q33867797Transfusion associated graft-versus-host disease, cytomegalovirus infection and HLA alloimmunization in neonatal and pediatric patients
Q33573262Transfusion practice in a Canadian hospital. Use of a major European study of transfusion practice for comparison as a form of audit
Q33559876Transfusion support in liver transplantation
Q33569828Transfusion-associated graft-versus-host disease (TA-GVHD): cellular mechanisms and their possible modulation by ultraviolet radiation
Q33569846Transfusion-associated graft-versus-host disease: current concepts and future trends
Q34094838Transfusional iron overload and chelation therapy with deferoxamine and deferiprone (L1).
Q77123400Translumbar inferior vena cava catheters: experience with 58 catheters in peripheral stem cell collection and transplantation
Q30321948Treatment of Guillain-Barré syndrome: listening carefully to the music before jumping on the bandwagon.
Q77052018Treatment of Sézary syndrome with extracorporeal photochemotherapy
Q33569394Treatment of autoimmune disease by immunomodulation through extracorporeal elimination and intravenous immunoglobulin
Q73325672Treatment of chronic dysimmune polyneuropathies
Q33583452Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: a review of US clinical studies 1987-1990. Hemophilia Study Group
Q77110702Treatment of graft versus host disease (GVHD) by photopheresis?
Q74822448Treatment of homozygous familial hypercholesterolemia by plasma exchange and LDL-apheresis
Q64972719Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
Q77157606Treatment of severe myasthenia gravis with protein A immunoadsorption and cyclophosphamide
Q33808870Treatment of the adult Guillain-Barré syndrome: indications for plasma exchange.
Q77052584U.K. guidelines for the irradiation of blood components
Q33930309UK strategy for process qualification/validation: from concept to practical implementation
Q40650706Unexpected hemoglobin electrophoresis results following red cell exchange in a sickle cell anemia patient with acute chest syndrome
Q77819976Universal leucodepletion--practical and regulatory consequences
Q74828243Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies
Q33564454Unrelated donor marrow transplantation for severe aplastic anaemia
Q33648322Update on leucocyte depletion of blood components by filtration
Q73252070Using SQUID biomagnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases
Q73625002Utility and quality of autologous fresh frozen plasma and autologous fibrin glue for surgical patients
Q74107539Utility of red blood cell apheresis in autologous blood donation
Q77819981Validation approaches selective/universal leucodepletion: the need for standardised validation strategies
Q77819946Variation in weights of fresh frozen plasma
Q74822442Viability of platelets collected by apheresis versus the platelet-rich plasma technique: a direct comparison
Q33329009Virus-associated idiopathic thrombocytopenic purpura
Q33761832What's happening? Cord blood derived stem cells: current views
Q33940148What's happening? Current status of high dose chemotherapy in breast cancer
Q33940153What's happening? Protein A columns: current concepts and recent advances
Q77070724What's happening?: Stem cells. Current developments in haematopoietic progenitor cell transplantation
Q33581238When less is more: cost-containment in transfusion medicine
Q74107519White cell subsets in filtered red blood cell concentrates
Q73689826nvCJD and leucodepletion: an overview

Q34118818Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donorscites workP2860

Search more.